Anebulo Pharmaceuticals, Inc. (ANEB) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $487.7K | +87.2% |
| 2024 | $260.6K | -75.6% |
| 2023 | $1.07M | +108.5% |
| 2022 | $512.5K | +112.1% |
| 2021 | $241.6K | +7.9% |
| 2020 | $223.9K | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $487.7K | +87.2% |
| 2024 | $260.6K | -75.6% |
| 2023 | $1.07M | +108.5% |
| 2022 | $512.5K | +112.1% |
| 2021 | $241.6K | +7.9% |
| 2020 | $223.9K | — |